not tagged
sanofi
['multiple myeloma', 'regeneron']
we look forward to hearing from voices from leading research institutes around the world as they discuss emerging therapies in triple class refractory multiple myeloma at #eha2022: 
Official channel for Regeneron. We turn science into medicine for people with serious diseases. View our terms of engagement here https://t.co/of3QRL6CsA